Dihydroergotamine Mesylate and Emtricitabine and tenofovir
Determining the interaction of Dihydroergotamine Mesylate and Emtricitabine and tenofovir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: emtricitabine / tenofovir
Brand name: AccessPak for HIV PEP Basic, Descovy, Truvada
Synonyms: Emtricitabine and Tenofovir Disoproxil Fumarate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Emtricitabine and Tenofovir Alafenamide
- Dihydroergotamine Mesylate-Emtricitabine and Tenofovir Disoproxil Fumarate
- Dihydroergotamine Mesylate-Emtricitabine and Tenofovir Tablets
- Dihydroergotamine Mesylate-Emtricitabine Capsules
- Dihydroergotamine Mesylate-Emtricitabine Solution
- Dihydroergotamine Mesylate-Emtricitabine, lopinavir, ritonavir, and tenofovir
- Emtricitabine and tenofovir-Dihydroergotamine nasal
- Emtricitabine and tenofovir-Dihydroergotamine Nasal Spray
- Emtricitabine and tenofovir-Dilacor XR
- Emtricitabine and tenofovir-Dilantin
- Emtricitabine and tenofovir-Dilantin Infatabs
- Emtricitabine and tenofovir-Dilantin injection